Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
AMN
|
Susan R Salka
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,882 Reduced 4.82% |
$198,368
$68.83 p/Share
|
Dec 17
2020 |
AMN
|
Susan R Salka
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,322 Added 10.91% |
-
|
Dec 17
2020 |
GMED
|
David M Demski
President, CEO |
SELL
Open market or private sale
|
Direct | 164,719 Reduced 100.0% |
$10,574,959
$64.2 p/Share
|
Dec 17
2020 |
GMED
|
David M Demski
President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 15,864 Added 8.78% |
$382,322
$24.1 p/Share
|
Dec 17
2020 |
DVA
|
John M Nehra
Director |
SELL
Bona fide gift
|
Indirect | 430 Reduced 0.7% |
-
|
Dec 17
2020 |
SSNC
|
Joseph J. Frank
SVP, Chief Legal Officer |
BUY
Open market or private purchase
|
Direct | 0 Added 0.0% |
$0
$72.21 p/Share
|
Dec 17
2020 |
LBRDA
|
John C Malone
Director |
SELL
Open market or private sale
|
Direct | 54,840 Reduced 2.49% |
$8,846,240
$161.31 p/Share
|
Dec 17
2020 |
SNAP
|
Jeremi Gorman
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 15,853 Reduced 0.77% |
$835,453
$52.7 p/Share
|
Dec 17
2020 |
IBKR
|
Paul Jonathan Brody
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 1,165 Reduced 0.32% |
$69,364
$59.54 p/Share
|
Dec 17
2020 |
IBKR
|
Thomas Aj Frank
Executive Vice President |
SELL
Open market or private sale
|
Direct | 7,410 Reduced 0.45% |
$441,117
$59.53 p/Share
|
Dec 17
2020 |
HPQ
|
Tracy S Keogh
Chief HR Officer |
SELL
Open market or private sale
|
Direct | 81,030 Reduced 23.43% |
$1,956,874
$24.15 p/Share
|
Dec 17
2020 |
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 74 Added 0.0% |
$112
$1.51 p/Share
|
Dec 17
2020 |
PDLI
|
Silver Point Capital L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 398,000 Added 2.54% |
$1,038,780
$2.61 p/Share
|
Dec 17
2020 |
ICD
|
Msd Capital L P
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,045 Reduced 0.53% |
$3,459
$3.31 p/Share
|
Dec 17
2020 |
EFT
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 97,462 Added 1.64% |
$1,296,245
$13.3 p/Share
|
Dec 17
2020 |
FSLF
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.6% |
$69,400
$13.88 p/Share
|
Dec 17
2020 |
VTA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 114,696 Added 1.25% |
$1,196,279
$10.43 p/Share
|
Dec 17
2020 |
ICD
|
Msd Partners, L.P. |
SELL
Open market or private sale
|
Indirect | 4,381 Reduced 0.53% |
$14,501
$3.31 p/Share
|
Dec 17
2020 |
SPRO
|
Aquilo Capital Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 250,000 Reduced 5.98% |
$4,702,500
$18.81 p/Share
|
Dec 17
2020 |
MDVL
|
Abg Wtt Med Avail LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 14,954 Added 0.11% |
$202,776
$13.56 p/Share
|
Dec 17
2020 |
THC
|
Glenview Capital Management, LLC |
SELL
Open market or private sale
|
Indirect | 185,000 Reduced 1.0% |
$7,620,150
$41.19 p/Share
|
Dec 17
2020 |
ZM
|
Eric S. Yuan
Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct | 70,142 Added 50.0% |
-
|
Dec 17
2020 |
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 70,142 Reduced 100.0% |
$28,347,189
$404.14 p/Share
|
Dec 17
2020 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$1,380,000
$138.0 p/Share
|
Dec 17
2020 |
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 27,400 Reduced 0.05% |
$8,494
$0.31 p/Share
|
Dec 17
2020 |
NVTA
|
Jason W. Myers
Director |
SELL
Bona fide gift
|
Direct | 300,000 Reduced 24.17% |
-
|
Dec 17
2020 |
NVTA
|
Jason W. Myers
Director |
SELL
Open market or private sale
|
Direct | 50,692 Reduced 3.92% |
$2,401,787
$47.38 p/Share
|
Dec 17
2020 |
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 7,000 Reduced 0.03% |
$1,680
$0.24 p/Share
|
Dec 17
2020 |
ARWR
|
Douglas B Given
Director |
SELL
Open market or private sale
|
Indirect | 500 Reduced 3.23% |
$39,795
$79.59 p/Share
|
Dec 17
2020 |
ARWR
|
Douglas B Given
Director |
SELL
Open market or private sale
|
Direct | 9,075 Reduced 7.33% |
$719,648
$79.3 p/Share
|
Dec 17
2020 |
TRTX
|
Matthew Coleman
President |
BUY
Grant, award, or other acquisition
|
Direct | 84,000 Added 47.21% |
-
|
Dec 17
2020 |
TRTX
|
Deborah J. Ginsberg |
BUY
Grant, award, or other acquisition
|
Direct | 9,746 Added 16.87% |
-
|
Dec 17
2020 |
TRTX
|
Avi Banyasz |
BUY
Grant, award, or other acquisition
|
Direct | 23,014 Added 27.42% |
-
|
Dec 17
2020 |
TRTX
|
Kelvin L. Davis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,014 Added 32.07% |
-
|
Dec 17
2020 |
TRTX
|
Robert Foley
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 19,980 Added 18.64% |
-
|
Dec 17
2020 |
TRTX
|
Peter A. Smith |
BUY
Grant, award, or other acquisition
|
Direct | 43,859 Added 21.32% |
-
|
Dec 17
2020 |
TRTX
|
Greta Guggenheim
CEO & President |
BUY
Grant, award, or other acquisition
|
Direct | 64,571 Added 9.72% |
-
|
Dec 17
2020 |
PRLE
|
Dennis Chookaszian
Director |
BUY
Grant, award, or other acquisition
|
Direct | 26,086 Added 21.59% |
-
|
Dec 17
2020 |
PRLE
|
Paul T Lambert
Director |
BUY
Grant, award, or other acquisition
|
Direct | 13,043 Added 12.76% |
-
|
Dec 17
2020 |
PRLE
|
Kathy M Jassem
Director |
BUY
Grant, award, or other acquisition
|
Direct | 17,478 Added 30.33% |
-
|
Dec 17
2020 |
CYTH
|
Francis Patrick Ostronic
Director |
BUY
Open market or private purchase
|
Direct | 30,000 Added 33.88% |
$139,200
$4.64 p/Share
|
Dec 17
2020 |
AIM
|
Thomas K Equels
CEO & President |
BUY
Open market or private purchase
|
Direct | 14,535 Added 6.82% |
$25,000
$1.72 p/Share
|
Dec 17
2020 |
HVBC
|
Robert Joseph Marino
Vice-Chair and President |
BUY
Open market or private purchase
|
Indirect | 567 Added 0.98% |
$9,696
$17.1 p/Share
|
Dec 17
2020 |
HVBC
|
Hugh W Connelly
EVP/CLO |
BUY
Open market or private purchase
|
Direct | 100 Added 1.22% |
$1,695
$16.95 p/Share
|
Dec 17
2020 |
TSOI
|
Timothy G Dixon
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 5,000,000 Added 1.82% |
$50,000
$0.01 p/Share
|
Dec 17
2020 |
TSOI
|
Thomas Ichim
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,000,000 Added 3.05% |
$50,000
$0.01 p/Share
|
Dec 17
2020 |
VTVT
|
Ronald O Perelman
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 625,000 Added 1.68% |
$1,000,000
$1.6 p/Share
|
Dec 17
2020 |
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 16.74% |
$330,000
$41.25 p/Share
|
Dec 17
2020 |
CBFV
|
John J La Carte
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 0.41% |
$3,075
$20.5 p/Share
|
Dec 17
2020 |
FNRN
|
Louise A Walker |
SELL
Bona fide gift
|
Direct | 4,117 Reduced 3.25% |
$39,976
$9.71 p/Share
|
Dec 17
2020 |